Bardy Diagnostics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Seattle, WA USA
Total Funding:$35.5M
Industry:Medical Equip
Founded:N/A
Lead Investor(s):SV Health Investors, Health Enterprise Partners

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Bardy Diagnostics's estimated annual revenue is currently $32.6M per year.
  • Bardy Diagnostics received $Undisclosed in venture funding in July 2018.
  • Bardy Diagnostics's estimated revenue per employee is $251,000
  • Bardy Diagnostics's total funding is $35.5M.

Employee Data

  • Bardy Diagnostics has 130 Employees.
  • Bardy Diagnostics grew their employee count by 41% last year.
  • Bardy Diagnostics currently has 2 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$12.3M49N/AN/A-N/A
#2
$10.3M41N/AN/A-N/A
#3
$43.4M173N/AN/A-N/A
#4
$154.9M617N/AN/A-N/A
#5
$8.8M3567%N/A-N/A
#6
$527.4M2101N/AN/A-N/A
#7
$70.8M2825%N/A-N/A
#8
N/A11N/AN/A-N/A
#9
$186.2M742N/AN/A-N/A
#10
N/A951N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Bardy Dx was founded to address the long-standing complaint in cardiac arrhythmia monitoring that traditional monitors were large, bulky, uncomfortable, and typically recorded noisy QRS signals. Our goal: to completely redesign an arrhythmia monitor with optimal signal detection, comfort, and ease of use. CAM is the first P-wave centric ECG monitor - a single-patient use monitor that records continuously for up to 7 days. This focus on the P-wave is a major new tool for cardiologists and cardiac rhythm specialists for accurately diagnosing arrhythmias.

keywords:N/A

130

Number of Employees

$32.6M

Revenue (est)

2

Current Jobs

41%

Employee Growth %

$35.5M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Bardy Diagnostics News

09/07/2019 - Bardy Diagnostics™ Receives FDA 510(k) Clearance for 14 ...

SEATTLE, Sept. 6, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc. Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring ...

09/08/2019 - FDA clears 14-Day version of ambulatory cardiac patch ...

The clearance was received by Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data ...

08/15/2019 - Bardy Diagnostics Selected for HealthTech Arkansas ...

August 15, 2019 — Bardy Diagnostics Inc. announced that HealthTech Arkansas, a healthcare accelerator and investment fund that connects early-stage ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A130N/AN/A-N/A
#2
$35.1M130N/AN/A-N/A
#3
N/A13021%N/A-N/A
#4
$35.1M130N/AN/A-N/A
#5
$26.3M130N/AN/A-N/A

Bardy Diagnostics Funding

DateAmountRoundLead InvestorsReference
2017-01-06$UndisclosedUndisclosedMultipleArticle
2018-07-19$UndisclosedUndisclosedSV Health InvestorsArticle

Bardy Diagnostics Executive Hires

DateNameTitleReference
2018-04-03Ken NelsonChief Commercial OfficerArticle